PubRank

T Tracy

Author PubWeight™ 46.65‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women. J Lab Clin Med 1994 1.64
2 Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop Relat Res 2001 1.60
3 Resistance to activated protein C and Legg-Perthes disease. Clin Orthop Relat Res 1997 1.55
4 Congenital bronchopulmonary malformations. Diagnostic and therapeutic considerations. J Thorac Cardiovasc Surg 1990 1.55
5 A preliminary pilot study of treatment of thrombophilia and hypofibrinolysis and amelioration of the pain of osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998 1.52
6 Gemfibrozil-lovastatin therapy for primary hyperlipoproteinemias. Am J Cardiol 1992 1.42
7 Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis. Clin Orthop Relat Res 1997 1.34
8 Congenital diaphragmatic hernia beyond infancy. Am J Surg 1991 1.33
9 Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their first-degree relatives. Metabolism 1991 1.31
10 Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2. J Lipid Res 1982 1.19
11 Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome. Metabolism 1999 1.19
12 The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis. Clin Orthop Relat Res 1999 1.17
13 In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6. Br J Clin Pharmacol 2000 1.08
14 Hypofibrinolysis: a common, major cause of osteonecrosis. Am J Hematol 1994 1.07
15 Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. Metabolism 1999 1.05
16 Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a), and therapy with Stanozolol. Am J Hematol 1995 0.97
17 Short-bowel syndrome in children. Quality of life in an era of improved survival. Arch Surg 1991 0.97
18 Increased expression of intercellular adhesion molecules in biliary atresia. Am J Pathol 1994 0.94
19 Differential expression of the major histocompatibility antigens and ICAM-1 on bile duct epithelial cells in biliary atresia. Tohoku J Exp Med 1997 0.93
20 Protein C and S deficiency, thrombophilia, and hypofibrinolysis: pathophysiologic causes of Legg-Perthes disease. Pediatr Res 1994 0.93
21 Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease. Am J Cardiol 1999 0.92
22 Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis? Thromb Haemost 1993 0.92
23 Secondhand smoke, hypofibrinolysis, and Legg-Perthes disease. Clin Orthop Relat Res 1998 0.92
24 Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS). J Adolesc Health 2001 0.92
25 Blood pressure lowering in elderly subjects: a double-blind crossover study of omega-3 and omega-6 fatty acids. Am J Clin Nutr 1991 0.91
26 Safety and efficacy of treatment of pediatric cholesteryl ester storage disease with lovastatin. Pediatr Res 1992 0.89
27 Parenteral nutrition-associated cholestasis. Semin Pediatr Surg 2001 0.88
28 Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am J Cardiol 1995 0.88
29 Lack of concordance in classification of coronary heart disease risk: high-risk HDL cholesterol less than 35 mg/dl in subjects with desirable total serum cholesterol, less than 200 mg/dl. J Lab Clin Med 1990 0.85
30 Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men. J Lab Clin Med 1993 0.85
31 The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications. Metabolism 2000 0.84
32 Familial idiopathic osteonecrosis mediated by familial hypofibrinolysis with high levels of plasminogen activator inhibitor. Thromb Haemost 1994 0.84
33 A clinical-pathological study of nonsurvivors of newborn ECMO. J Pediatr Surg 1993 0.83
34 Congenital diaphragmatic hernia repair on ECMO. J Pediatr Surg 1990 0.82
35 Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer. Metabolism 1993 0.82
36 Pediatric victims of unexplained stroke and their families: familial lipid and lipoprotein abnormalities. Pediatrics 1982 0.82
37 Improvement in symptoms of depression and in an index of life stressors accompany treatment of severe hypertriglyceridemia. Biol Psychiatry 1993 0.81
38 Hypocholesterolemia and affective disorders. Am J Med Sci 1994 0.81
39 Contribution of fasting hyperinsulinemia to prediction of atherosclerotic cardiovascular disease status in 293 hyperlipidemic patients. Metabolism 1999 0.81
40 Thrombophilia, hypofibrinolysis, and alveolar osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996 0.81
41 Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the factor V Leiden mutation (resistance to activated protein C). Am J Cardiol 1999 0.79
42 Organizational change from the "mom and pop" perspective. J Nurs Adm 1992 0.79
43 Risk factors for coronary heart disease among firefighters in Cincinnati. Am J Ind Med 1996 0.78
44 The common finding of covert hypothyroidism at initial clinical evaluation for hyperlipoproteinemia. Clin Chim Acta 1991 0.78
45 The risk of abdominal operations in children with ventriculoperitoneal shunts. J Pediatr Surg 1992 0.77
46 A matched pairs analysis of venoarterial and venovenous extracorporeal life support in neonatal respiratory failure. ASAIO J 1996 0.77
47 The pathophysiology of alveolar osteonecrosis of the jaw: anticardiolipin antibodies, thrombophilia, and hypofibrinolysis. J Lab Clin Med 1996 0.77
48 Safety and efficacy of combined gemfibrozil-lovastatin therapy for primary dyslipoproteinemias. J Lab Clin Med 1990 0.75
49 Achiral and chiral HPLC analysis of norverapamil and its metabolites in microsomal samples. Neoplasma 1999 0.75
50 Capillary plasma lipid profiles. Clin Chim Acta 1991 0.75
51 Current concepts in neuroblastoma. Surg Annu 1992 0.75
52 Ileoproctostomy with J-pouch: use of the Swenson pull-through for reconstruction after proctocolectomy for ulcerative colitis. J Pediatr Surg 1986 0.75
53 Changes in plasma lipid and lipoprotein fractions after alteration in dietary cholesterol, polyunsaturated, saturated, and total fat in free-living normal and hypercholesterolemic children. Am J Clin Nutr 1982 0.75
54 Malignant fibrous histiocytomas in children. J Pediatr Surg 1984 0.75
55 Inheritance conjointly contributing to fibrinolysis and hyperlipidemia. Metabolism 1993 0.75
56 Beta blockers, Lp(a), hypertension, and reduced basal fibrinolytic activity. Am J Med Sci 1994 0.75
57 Mucosal proliferation characteristics in ureterosigmoidostomy: effect of calcium supplement. J Pediatr Surg 1990 0.75
58 Nitrogen balance in patients treated with extracorporeal membrane oxygenation. J Pediatr Surg 1993 0.75
59 Right pneumonectomy syndrome: a lethal complication of lung resection in a newborn with cystic adenomatoid malformation. J Pediatr Surg 1988 0.75
60 Cholesterol screening in 5,719 self-referred elderly subjects. J Gerontol 1990 0.75
61 The keys to the executive suite. Nurs Adm Q 2001 0.75
62 Cricoid split for subglottic stenosis in infancy. Ann Thorac Surg 1988 0.75
63 Whether, to what degree, and why lipoprotein(a) levels change over time. Clin Chim Acta 1995 0.75
64 Developmental practicum experiences of preservice teachers in deaf education: implications for practicum placement and faculty-student collaborative research. Am Ann Deaf 2000 0.75
65 We need research on psychosocial occupational therapy. Am J Occup Ther 1992 0.75
66 Therapists in mental health need to become more visible. Am J Occup Ther 1988 0.75
67 Tracking of high- and low-density-lipoprotein cholesterol from childhood to young adulthood in a single large kindred with familial hypercholesterolemia. Metabolism 1985 0.75